Literature DB >> 4309337

The isolation of parainfluenza 4 subtypes A and B in England and serological studies of their prevalence.

S D Gardner.   

Abstract

Mesh：

Substances：

Year:  1969        PMID： 4309337      PMCID： PMC2130730          DOI： 10.1017/s002217240004198x

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN： 0022-1724


× No keyword cloud information.
  5 in total

1.  ANTIGENIC VARIATION AMONG NEWLY ISOLATED STRAINS OF PARAINFLUENZA TYPE 4 VIRUS.

Authors:  J CANCHOLA; A J VARGOSKO; H W KIM; R H PARROTT; E CHRISTMAS; B JEFFRIES; R M CHANOCK
Journal:  Am J Hyg       Date:  1964-05

2.  Para-influenza viruses 1, 2, and 3: suggested names for recently described myxoviruses.

Authors:  C H ANDREWES; F B BANG; R M CHANOCK; V M ZHDANOV
Journal:  Virology       Date:  1959-05       Impact factor: 3.616

3.  Newly recognized myxoviruses from children with respiratory disease.

Authors:  R M CHANOCK; R H PARROTT; K COOK; B E ANDREWS; J A BELL; T REICHELDERFER; A Z KAPIKIAN; F M MASTROTA; R J HUEBNER
Journal:  N Engl J Med       Date:  1958-01-30       Impact factor: 91.245

4.  [Strains of parainfluenza virus type 4, isolated in a day nursery].

Authors:  E Zilisteanu; I Nafta; L Creţesco; I Nicoulesco; M Focşăneanu
Journal:  Arch Roum Pathol Exp Microbiol       Date:  1966-06

5.  Association of a new type of cytopathogenic myxovirus with infantile croup.

Authors:  R M CHANOCK
Journal:  J Exp Med       Date:  1956-10-01       Impact factor: 14.307
  5 in total
  17 in total

1.  Viruses and respiratory infection in childhood.

Authors:  P Gardner
Journal:  Proc R Soc Med       Date:  1976-09

2.  Diagnosis and clinical significance of parainfluenza virus infections in children.

Authors:  M A Downham; J McQuillin; P S Gardner
Journal:  Arch Dis Child       Date:  1974-01       Impact factor: 3.791

3.  Parainfluenza virus infections.

Authors:  S K Clarke
Journal:  Postgrad Med J       Date:  1973-11       Impact factor: 2.401

4.  Human parainfluenza virus 4 outbreak and the role of diagnostic tests.

Authors:  Susanna K P Lau; Wing-Kin To; Philomena W T Tse; Alex K H Chan; Patrick C Y Woo; Hoi-Wah Tsoi; Annie F Y Leung; Kenneth S M Li; Paul K S Chan; Wilina W L Lim; Raymond W H Yung; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013-2017, reveals distinct disease features and co-circulating genomic subtypes.

Authors:  Akhil Chellapuri; Matthew Smitheman; Joseph G Chappell; Gemma Clark; Hannah C Howson-Wells; Louise Berry; Jonathan K Ball; William L Irving; Alexander W Tarr; C Patrick McClure
Journal:  Influenza Other Respir Viruses       Date:  2022-06-07       Impact factor: 5.606

6.  Clinical and molecular epidemiology of human parainfluenza virus 4 infections in hong kong: subtype 4B as common as subtype 4A.

Authors:  Susanna K P Lau; Kenneth S M Li; Kam-yu Chau; Lok-yee So; Rodney A Lee; Yu-lung Lau; Kwok-hung Chan; Wilina W L Lim; Patrick C Y Woo; Kwok-yung Yuen
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

Review 7.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

8.  Epidemiology and clinical presentation of the four human parainfluenza virus types.

Authors:  Wen-Kuan Liu; Qian Liu; De-Hui Chen; Huan-Xi Liang; Xiao-Kai Chen; Wen-Bo Huang; Sheng Qin; Zi-Feng Yang; Rong Zhou
Journal:  BMC Infect Dis       Date:  2013-01-23       Impact factor: 3.090

9.  Discovery of a divergent HPIV4 from respiratory secretions using second and third generation metagenomic sequencing.

Authors:  David E Alquezar-Planas; Tobias Mourier; Christian A W Bruhn; Anders J Hansen; Sarah Nathalie Vitcetz; Søren Mørk; Jan Gorodkin; Hanne Abel Nielsen; Yan Guo; Anand Sethuraman; Ellen E Paxinos; Tongling Shan; Eric L Delwart; Lars P Nielsen
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Human parainfluenza type 4 infections, Canada.

Authors:  Marie-Louise Vachon; Natasha Dionne; Eric Leblanc; Danielle Moisan; Michel G Bergeron; Guy Boivin
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.